Cryptosporidium sp. is a ubiquitous 4-to 6-,um protozoan parasite infecting the intestinal tract of humans. It causes mild to fulminant diarrhea in patients, especially immunocompromised persons, and it may be hard to detect by microscopic fecal examination. An indirect, double-antibody enzyme-linked immunosorbent assay (ELISA) was developed using specifically produced goat and rabbit antisera to detect Cryptosporidium antigens in human feces. Of 62 frozen stools from patients with cryptosporidiosis, as detected by at least two microscopic diagnostic techniques, 51 were positive by ELISA; all ELISA-negative specimens came from patients with fewer than five oocysts per 0.01 ml of concentrated fecal sample examined after modified acid-fast or fluorescent monoclonal antibody staining. A total of 182 specimens from persons without Cryptosporidium infection were negative by ELISA in 176 instances; 3 ELISA-positive specimens came from patients with cryptosporidiosis diagnosed earlier. The sensitivity of the assay was 82.3%, and specificity was 96.7%. The predictive value of a positive ELISA was 89.5%, and the predictive value of a negative ELISA was 94.2%. The ELISA was not affected by the presence of eight other intestinal parasites but was sometimes affected by repeated freezing and thawing of fecal specimens. All fecal specimens were heated to 100°C for 2 min to reduce proteolytic enzyme activity, although the necessity of this step needs further evaluation. This first-generation ELISA is a simple, rapid, easily standardized test for Cryptosporidium antigens in stool samples which will be useful for diagnosis and for large-scale epidemiologic studies.
Cryptosporidium sp. is a ubiquitous 4-to 6-,um protozoan parasite infecting the intestinal tract of humans. It causes mild to fulminant diarrhea in patients, especially immunocompromised persons, and it may be hard to detect by microscopic fecal examination. An indirect, double-antibody enzyme-linked immunosorbent assay (ELISA) was developed using specifically produced goat and rabbit antisera to detect Cryptosporidium antigens in human feces. Of 62 frozen stools from patients with cryptosporidiosis, as detected by at least two microscopic diagnostic techniques, 51 were positive by ELISA; all ELISA-negative specimens came from patients with fewer than five oocysts per 0.01 ml of concentrated fecal sample examined after modified acid-fast or fluorescent monoclonal antibody staining. A total of 182 specimens from persons without Cryptosporidium infection were negative by ELISA in 176 instances; 3 ELISA-positive specimens came from patients with cryptosporidiosis diagnosed earlier. The sensitivity of the assay was 82.3%, and specificity was 96.7%. The predictive value of a positive ELISA was 89.5%, and the predictive value of a negative ELISA was 94.2%. The ELISA was not affected by the presence of eight other intestinal parasites but was sometimes affected by repeated freezing and thawing of fecal specimens. All fecal specimens were heated to 100°C for 2 min to reduce proteolytic enzyme activity, although the necessity of this step needs further evaluation. This first-generation ELISA is a simple, rapid, easily standardized test for Cryptosporidium antigens in stool samples which will be useful for diagnosis and for large-scale epidemiologic studies.
Cryptosporidium sp. is a 4-to 6-,um coccidian parasite of veterinary importance, recognized worldwide as a human pathogen which causes self-limited diarrhea in immunocompetent patients and potentially intractable diarrhea in immunodeficient hosts (5, 6, 22) . Prevalence is greater than 30% in some less-developed countries, although it rarely exceeds 2% in more-developed countries, except in specialized populations, such as acquired immunodeficiency syndrome patients or household members of infected patients, or in outbreaks, either waterborne or in hospitals and day-care centers (5, 6, 22; B. L. P. Ungar, in J. P. Dubey, C. A. Speer, and R. Fayer, ed., Cryptosporidiosis in Man and Animals, in press).
Until the acquired immunodeficiency syndrome pandemic gave human cryptosporidiosis a new importance, diagnosis relied on the identification of organisms in intestinal biopsy sections, frequently by electron microscopy. In the last decade, more than six concentration methods and more than a dozen staining techniques to detect oocysts in fecal specimens have been developed without consensus as to diagnostic dependability (5, 6) . In the United States, as many as three different techniques may be used in a single laboratory; concentration by flotation in Sheather's sugar solution, modified acid-fast and fluorescent stains, and monoclonal antibody-based assays are most often used (7-9, 15, 23, 25) . Nevertheless, Cryptosporidium oocysts may be hard to detect except in laboratories with the repeated and continuous exposure to positive specimens that allows diagnostic
proficiency. An indirect double-antibody enzyme-linked immunosorbent assay (ELISA) was developed to detect Cryptosporidium antigens in fecal specimens.
MATERIALS AND METHODS
Preparation of immunogen. Cryptosporidium oocysts were purified from calf feces by a modification of an earlier described technique (29) . Fecal fat was removed by 10% ethyl acetate in deionized water (7 ml of feces to 25 ml of 10% ethyl acetate). Oocysts were separated from fecal material by flotation in sodium chloride-saturated deionized water (25 ml) and by sedimentation in deionized water (50 ml) after 10 min of centrifugation (4°C) at 1,000 x g. Other contaminating material was removed by treatment with 1% sodium hypochlorite in deionized water (20 ml) at room temperature for 1 min. After centrifugation as before, the resulting pellet of organisms was washed three times as follows: it was suspended by shaking in demonized water (50 ml) and recentrifuged. The final pellet was suspended in 1 Fresh specimens were examined in the laboratory of original submission by direct microscopy after concentration and/or after modified acid-fast or fluorescent monoclonal antibody staining (8, 15, 23 To calculate results, the mean OD reading of wells coated with preimmune rabbit sera was subtracted from the mean OD of wells coated with immune rabbit sera to yield the specific OD for a given specimen. The mean and standard deviation of the OD for the negative control fecal specimens were calculated as described above. A clinical specimen was considered positive if the specific OD value was 0.08 U greater than the mean plus 2 standard deviations of the specific OD of at least five simultaneously examined negative control specimens (30, 31) . A dilution of Cryptosporidium oocysts was considered positive if it yielded a value greater than that of the buffer alone.
RESULTS
Ability of ELISA to detect known numbers of Crytoposporidium oocysts. Serial twofold dilutions containing from 500,000 to 2 Cryptosporidium organisms per 0.1 ml were examined in duplicate. The ELISA was easily able to detect between approximately 2,000 and 4,000 purified Cryptosporidium oocysts in six comparable ELISAs run on different days. It was able to detect between approximately 1,000 and 2,000 purified Cryptosporidium oocysts in two additional ELISAs run on other days.
Testing of clinical specimens. As shown in Fig. 1 , 51 of 62 specimens from patients with confirmed cryptosporidiosis were positive by ELISA. All of the 11 remaining specimens of this group came from patients with fewer than five oocysts per 0.01 ml of concentrated fecal specimen, and 10 of these were from Peruvians. Of 182 samples from patients without confirmed cryptosporidiosis, 176 were negative by ELISA. Three of the six ELISA-positive, microscopy-negative specimens came from persons with cryptosporidiosis 30 to 60 days earlier, and two came from persons with Cryptosporidium oocysts identified by one, but unconfirmed by a second, stool examination. There was no medical history or additional specimen available from the final patient in this group.
Compared with results of a microscopic examination (Table 1) , the overall sensitivity of the assay was 82.3%, with a false-negative rate of 17.7%. Specificity was 96.7%, with a false-positive rate of 3.3%. The predictive value of a positive ELISA was 89.5%, and the predictive value of a negative ELISA was 94.2%.
Limits of ability of ELISA to detect Cryptosporidium antigen. Some ELISA-positive specimens lost and some retained detectable Cryptosporidium antigen after a minimum Examination of positive and negative specimens in various locations on the same microtiter plate showed no difference in overall positivity or negativity of the specimens. OD readings for six positive specimens examined on at least three instances during a 3-to 23-week period showed OD values which ranged from 0.110 to 0.476 absorbance units, and for no specimen did this value vary more than 0.2 U. For 16 negative specimens examined at least three times over an 8-week period, OD readings were greater than 0.002 on only 4 of 48 occasions, with the highest reading at 0.067.
DISCUSSION
During the past decade, as Cryptosporidium sp. has become acknowledged as an important human pathogen, numerous stool concentration and staining techniques that allow direct visualization of Cryptosporidium oocysts in fecal specimens have been developed (2, 4, 6, 8, 9, 12, 18, (21) (22) (23) 25) . These include the most commonly used modified acid-fast stain and monoclonal antibody-based fluorescence detection assays (1, 3, 7, 8, 21) . All microscopic diagnoses rely on direct visualization and morphologic recognition of small-size oocysts which may be scant in number, intermittently shed, or inconsistently stained (5; Ungar, in press). The use of fluorescence-based diagnostic tests is limited by expense and frequent lack of a fluorescence microscope, and other staining techniques, which may require examination of three or more fecal specimens to detect Cryptosporidium sp. (5), remain standard. Frequently, more than one technique may be necessary to diagnose Cryptosporidium sp., which is time-consuming and costly. Furthermore, recent identification of an acid-fast blue-green alga (cyanobacterium) which is only slightly larger than Cryptosporidium cells as a putative agent of diarrhea may limit the utility of acid-fast staining in the future (D. R. Shlim, M. T. Cohen, M. Eaton, R. Raja, E. G. Long, and B. L. P. Ungar, submitted for publication).
ELISAs have previously been developed for detection of E. histolytica and G. lamblia antigens in fecal specimens (10, 11, 13, 19, 20, 24, 26, (30) (31) (32) . For E. histolytica, an ELISA using a single conjugated specific antibody was developed in 1978 (19) , followed in 1982 by a double-antibody ELISA system (11) , further modified in 1985 to a double-antibody ELISA using a monoclonal antibody (31) . For G. lamblia, a double-antibody assay which was first described in 1984 (30) has been used with experimentally infected humans (17) (10, 13, 20, 24, 26, 32) , and recent modifications include the use of antisera to specific ubiquitous giardia antigens (20, 24) .
The ELISA for Cryptosporidium antigen detection in fecal specimens described here offers a diagnostic alternative to direct microscopy and represents the first generation of an ELISA for this organism. The sensitivity of the assay was 82.3% and specificity was 96.7%, with two separate positive microscopic examinations as the "gold standard" for positive diagnosis. At least three of the ELISA-positive, microscopy-negative specimens came from persons with previously documented cryptosporidiosis, suggesting either that microscopically undiagnosed Cryptosporidium sp. was still present or that the ELISA detected disintegrating organisms or their products; two other specimens of this group came from persons with only one unconfirmed positive microscopic examination, which may imply real infection or an ability to detect free antigen from some extracellular life cycle stage. In these cases, the ELISA may have detected cryptosporidiosis more efficiently than other means of diagnosis and may be important in identifying persons not actively excreting oocysts at the time of specimen collection, which is relevant to the transmission of infection (5; Ungar,  in press).
The failure ofthe ELISA to detect infections in specimens from 11 individuals (10 Peruvians) with fewer than five oocysts per 0.01 ml of concentrated fecal sample may suggest that these specimens contained antigen that was inaccessible to or not recognized by the detecting polyclonal antibodies. These polyclonal antibodies were raised to sonicated Cryptosporidium oocysts and therefore to both sporozoites and oocyst wall components. In (20, 26) .
Several studies have now identified Cryptosporidium antigens, particularly those in the 20-to 27-kDa molecular mass range, which may be immunogenic in most infected humans (16, 28) and which may be unique to C. parvum, the isolate which infects humans (14, 27 
